Evaluate Acquires Bioscience Advisors, Adding the Most Comprehensive Database of Biopharma Deals to Its Commercial Intelligence Portfolio

Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is delighted to announce that it has completed the acquisition of Bioscience Advisors Inc. (Biosci), a California-based data company focused on biopharma alliances. The acquisition will significantly expand the richness and quantity of biopharma deal data available to Evaluate clients, furthering Evaluate’s mission to provide the most complete and dynamic valuations of pharmaceutical assets.
（以上内容由医药魔方AI生成）